Astrazeneca Pharma India surges on delisting proposal

Shares in Astrazeneca Pharma India Ltd surge 20 percent to their maximum daily limit after the drug maker says its board would meet on Wednesday to discuss delisting proposal.

AstraZeneca Pharma India said in the filing before markets opened on Monday that its board received a request from its promoter, AstraZeneca Pharmaceuticals AB Sweden, to initiate a voluntary delisting process.

Astrazeneca Pharmaceuticals AB holds 75 percent in AstraZeneca Pharma India.

RELATED ARTICLES

EDITORIAL OF THE DAY

  • Finance ministry must stand its ground on lower EPF interest rate

    In quick succession, yet another controversy is brewing with regard to affairs of the employees provident fund organisation (EPFO).

FC NEWSLETTER

Stay informed on our latest news!

TODAY'S COLUMNS

Amita Sharma

Sanskrit: a victim of academic schizophrenia

J Robert Oppenheimer, the father of the atomic bomb and ...

Zehra Naqvi

God save the child

Childhood is supposed to be the best phase in life. ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture